M

MAVUPHARMA, INC.

10 employees

Non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease.

Basic info

Sectors

Biotechnology
Health Care
Pharmaceutical
Life Science

Date founded

2016

Funding rounds raised

Total raised

$20M

from 2 investors over 2 rounds

M

MAVUPHARMA, INC. raised $20M on November 29, 2017

Investors: Alpine BioVentures and Frazier Healthcare Partners

FAQ